Micheli Stéfani Zarzecki
Universidade Federal do Pampa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Micheli Stéfani Zarzecki.
Toxicology reports | 2014
Micheli Stéfani Zarzecki; Stífani Machado Araujo; Vandreza Cardoso Bortolotto; Mariane Trindade de Paula; Cristiano R. Jesse; Marina Prigol
Chrysin (5,7-dihydroxyflavone) is a flavonoid, natural component of traditional medicinal herbs, present in honey, propolis and many plant extracts. The objective of this study was to investigate the hypolipidemic properties of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice. Triton WR-1339 was administered intraperitoneally (400 mg/kg) to overnight-fasted mice to develop acute hyperlipidemia. Chrysin was administered orally (10 mg/kg) 30 min before Triton WR-1339. At 24 h after Triton WR-1339 injection, blood samples were collected to measure plasma lipid levels. The hepatic thiobarbituric acid reactive substances (TBARS), carbonyl content, non-protein sulfhydryl (NPSH) and ascorbic acid (AA) levels, as well as catalase (CAT) and superoxide dismutase (SOD) activity were recorded. Chrysin administration significantly decreased total cholesterol levels. In addition, it partially decreased non-high density lipoprotein-cholesterol and triglycerides levels in plasma of hyperlipidaemic mice. In addition chrysin administration prevented the increase on TBARS levels and prevented the decrease in SOD activity induced by Triton WR-1339. These findings indicated that chrysin was able to decrease plasma lipids concentration and that its antioxidant properties was, at least in part, involved in the hypolipidaemic action of chrysin.
Neurotoxicology | 2015
Stífani Machado Araujo; Mariane Trindade de Paula; Márcia Rósula Poetini; Luana Barreto Meichtry; Vandreza Cardoso Bortolotto; Micheli Stéfani Zarzecki; Cristiano R. Jesse; Marina Prigol
The γ-orizanol present in rice bran oil contains a mix of steryl triterpenyl esters of ferulic acid, which is believed to be linked to its antioxidant potential. In this study we investigated the neuroprotective actions of γ-orizanol (ORY) against the toxicity induced by rotenone (ROT) in Drosophila melanogaster. The flies (both genders) aged between 1 and 5 days old were divided into four groups of 50 flies each: (1) control, (2) ORY 25 μM, (3) ROT 500 μM, (4) ORY 25 μM+ROT 500 μM. Flies were concomitantly exposed to a diet containing ROT and ORY for 7 days according to their respective groups. Survival and behavior analyses were carried out in vivo, and ex vivo analyses involved acetylcholinesterase activity (AChE), determination of dopaminergic levels, cellular viability and mitochondrial viability, activities of superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), reactive species levels (RS), lipid peroxidation (TBARS) and contents of total thiols and non-proteic thiols (NPSH). Our results show for the first time that ORY not only acts as an endogenous activator of the cellular antioxidant defenses, but it also ameliorates rotenone induced mortality, oxidative stress and mitochondrial dysfunction. Our salient findings regarded the restoration of cholinergic deficits, dopamine levels and improved motor function provided by ORY. These results demonstrate the neuroprotective potential of ORY and that this effect can be potentially due to its antioxidant action. In conclusion, the present results show that ORY is effective in reducing the ROT induced toxicity in D. melanogaster, which showed a neuroprotective action, possibly due to the presence of the antioxidant constituents such as the ferulic acid.
Epilepsy Research | 2013
Bárbara P. Marquezan; Vinícius Rafael Funck; Clarissa Vasconcelos de Oliveira; Letícia Meier Pereira; Stífani Machado Araujo; Micheli Stéfani Zarzecki; Luiz Fernando Freire Royes; Ana Flávia Furian; Mauro Schneider Oliveira
The present study aimed to investigate whether Na(+),K(+)-ATPase activity and phosphorylation state of the catalytic α subunit are altered by pentylenetetrazol (PTZ)-induced seizures. PTZ (30, 45 or 60 g/kg, i.p.) was administered to adult male Swiss mice, and Na(+),K(+)-ATPase activity and phosphorylation state were measured in the cerebral cortex 15 min after PTZ administration. Na(+),K(+)-ATPase activity significantly decreased after PTZ-induced seizures (60 mg/kg). Immunoreactivity of phosphorylated Ser943 at α subunit was increased after PTZ-induced seizures. A significant positive correlation between Na(+),K(+)-ATPase activity and latency to myoclonic jerks and generalized seizures was found. Conversely, a strong negative correlation between Ser943 phosphorylation and latency to generalized seizures was detected. Given the role of Na(+),K(+)-ATPase as a major regulator of brain excitability, Ser943 at Na(+),K(+)-ATPase α subunit may represent a potentially valuable new target for drug development for seizure disorders.
Journal of Cellular Biochemistry | 2017
Micheli Stéfani Zarzecki; Vandreza Cardoso Bortolotto; Márcia Rósula Poetini; Stífani Machado Araujo; Mariane Trindade de Paula; Silvane Souza Roman; Cristiano Chiapinotto Spiazzi; Franciele Weber Santos Cibin; Oscar E. D. Rodrigues; Cristiano R. Jesse; Marina Prigol
This study aims to investigate the protective effect of p‐chloro‐phenyl‐selenoesterol [PCS; 0,2 mg/kg; 10 ml/kg i.g.) in colitis induced by 2,4,6‐trinitrobenzene sulfonic acid [TNBS; 2 mg/100 µl 50% ethanol; intrarectally) in mice. Several parameters including weight, length, histological analyses determination, thiobarbituric acid reactive species, reactive species levels, superoxide dismutase, catalase, and myeloperoxidase (MPO) activity of colon were evaluated. The serum levels of tumor necrosis factor alpha [TNF‐α) and interleukin 6 [IL‐6) were also assessed. Treatment with PCS reduced the clinical and histopathologic severity of TNBS‐induced colitis, characterized by colon length reduction and increased colon weight and microscopic intestinal inflammation. The therapeutic effects of PCS in this model were associated with significant decrease in proinflammatory cytokines TNF‐α and IL‐6 and decrease in MPO activity. Furthermore, combined with improvements in inflammatory parameters, treatment with the PCS was able to decrease oxidative stress and to prevent the decrease in antioxidant defenses in animals with TNBS‐induced colitis. This finding suggests that PCS can improve experimental colitis in mice and it could be a potential therapeutic agent for the treatment of patients with IBD. J. Cell. Biochem. 118: 709–717, 2017.
Anais do Salão Internacional de Ensino, Pesquisa e Extensão | 2016
Vandreza Cardoso Bortolotto; Marina Prigol; Micheli Stéfani Zarzecki; Márcia Rósula Poetini; Cristiano R. Jesse; Stífani Machado Araujo
Anais do Salão Internacional de Ensino, Pesquisa e Extensão | 2014
Vandreza Cardoso Bortolotto; Marina Prigol; Micheli Stéfani Zarzecki; Cristiano R. Jesse; Cristiano Chiapinotto Spiazzi; Oscar Rodruigues
Anais do Salão Internacional de Ensino, Pesquisa e Extensão | 2013
Vandreza Cardoso Bortolotto; Marina Prigol; Micheli Stéfani Zarzecki; Márcia Rósula Poetini Silva; José S.S. Neto; Franciane Cabral Pinheiro
Anais do Salão Internacional de Ensino, Pesquisa e Extensão | 2012
Stífani Machado Araujo; Micheli Stéfani Zarzecki; Marina Prigol; Cristiano R. Jesse
Anais do Salão Internacional de Ensino, Pesquisa e Extensão | 2012
Micheli Stéfani Zarzecki; Stífani Machado Araujo; Vandreza Cardoso Bortolotto; Elize Aparecida Santos Musachio; Marina Prigol
Anais do Salão Internacional de Ensino, Pesquisa e Extensão | 2011
Stífani Machado Araujo; Micheli Stéfani Zarzecki; Mauro Schneider Oliveira